Vasodilatory effect of tuberoinfundibular peptide (TIP39): Requirement of receptor desensitization and its beneficial effect in the post-ischemic heart

Peptides

Volumn 28, Issue 4, 2007, Pages 878-886

  Ross, Günter ^a   Heinemann, Marcus P ^a   Schlüter, Klaus Dieter ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Coronary system; Nitric oxide; Parathyroid hormone; Parathyroid hormone related protein; Vasodilatory peptides

Indexed keywords

HORMONE RECEPTOR BLOCKING AGENT; HORMONE RECEPTOR STIMULATING AGENT; NITRIC OXIDE; PARATHYROID HORMONE DERIVATIVE; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RECEPTOR 1; PARATHYROID HORMONE RECEPTOR 2; PARATHYROID HORMONE RELATED PROTEIN; TUBEROINFUNDIBULAR PEPTIDE 39; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY VASCULAR RESISTANCE; DESENSITIZATION; EXPERIMENTAL STUDY; FEMALE; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HORMONE RELEASE; ISOLATED HEART; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; VASODILATATION;

ANIMALS; BRADYKININ; FEMALE; HEART; MYOCARDIAL ISCHEMIA; NEUROPEPTIDES; PARATHYROID HORMONE-RELATED PROTEIN; RATS; RECEPTOR, PARATHYROID HORMONE, TYPE 1; RECEPTOR, PARATHYROID HORMONE, TYPE 2; TIME FACTORS; VASODILATOR AGENTS;

RATTUS;

EID: 33847384129     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.12.010     Document Type: Article

References (38)

1. Castro M., Dicker F., Vilrdaga J.P., Krasel C., Bernhartdt M., and Lohse M.J. Dual regulation of the parathyroid hormone (PTH)/PTH-related peptide receptor signalling by protein kinase C and beta-arrestins. Endocrinology 143 (2002) 3854-3865
2. Degenhardt H., Jansen J., Schulz R., Sedding D., Braun-Dullaeus R., and Schlüter K.-D. Mechanosensitive release of parathyroid hormone-related peptide from coronary endothelial cells. Am J Physiol Heart Circ Physiol 283 (2002) H1489-H1496
3. Della Penna K., Kinose F., Sun H., Koblan K.S., and Wang H. Tuberoinfundibular peptide of 39 residues (TIP39): molecular structure and activity for parathyroid hormone 2 receptor. Neuropharmacology 44 (2003) 141-153
4. Eichinger A., Fiaschi-Taesch N., Massfelder T., Fritsch S., Barthelmebs M., and Helwig J.J. Transcript expression of the tuberoinfundibular peptide (TIP)39/PTH2 receptor system and non-PTH1 receptor-mediated tonic effects of TIP39 and other PTH2 receptor ligands in renal vessels. Endocrinology 143 (2002) 3036-3043
5. Ferrari S.L., Behar V., Chorev M., Rosenblatt M., and Bisello A. Endocytosis of ligand-human parathyroid hormone receptor 1 complexes is protein kinase C-dependent and involves beta-arrestin2. Real-time monitoring by fluorescence microscopy. J Biol Chem 274 (1999) 29968-29975
6. Ferrari S.L., and Bisello A. Cellular distribution of constitutively active mutant parathyroid hormone (PTH)/PTH-related protein receptors and regulation of cyclic adenosine 3′,5′-monophosphate signalling by beta-arrestin 2. Mol Endocrinol 15 (2001) 149-163
7. Goold C.P., Usdin T.B., and Hoare S.R. Regions in rat and human parathyroid hormone (PTH) 2 receptors controlling receptor interaction with PTH and with antagonist ligands. J Pharmacol Exp Ther 299 (2001) 678-690
8. Hansen I.A., Jakob O., Wortmann S., Arzberger T., Allolio B., and Blind E. Characterization of the human and mouse genes encoding the tuberoinfundibular peptide of 39 residues, a ligand of the parathyroid hormone receptor family. J Endocrinol 174 (2002) 95-102
9. Jansen J., Gres P., Umschlag C., Heinzel F.R., Degenhardt H., Schlüter K.D., et al. Parathyroid hormone-related peptide improves contractile function of stunned myocardium in rats and pigs. Am J Physiol Heart Circ Physiol 284 (2003) H49-H55
10. Juppner H., Abou-Samara A.B., Freemann M., Kong X.F., Schipani E., Richards J., et al. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254 (1991) 1024-1026
11. Juppner H., Abou-Samra A.B., Uneno S., Gu W.X., Potts J.T., and Serge G.V. The parathyroid hormone-like peptide associated with humoral hypercalcemia of malignancy and parathyroid hormone bind to the same receptor on the plasma membrane of ROS 17/2.8 cells. J Biol Chem 263 (1988) 8557-8560
12. LaBuda C.J., Dobolyi A., and Usdin T.B. Tuberoinfundibular peptide of 39 residues produces anxiolytic and antidepressant actions. Neuroreport 15 (2004) 881-885
13. Laude K., Favre J., Thuillez C., and Richard V. NO produced by endothelial NO synthase is a mediator of delayed preconditioning-induced endothelial protection. Am J Physiol Heart Circ Res 284 (2003) H2053-H2060
14. Laude K., Thuillez C., and Richard V. Peroxynitrite triggers a delayed resistance of coronary endothelial cells against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 283 (2001) H1418-H1423
15. Lefer D.J., Scalia R., Campbell B., Nossuli T., Hayward R., Salamon M., et al. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest 99 (1997) 684-691
16. Malecz N., Bambino T., Bencsik M., and Nissenson R.A. Identification of phosphorylation sites in the G protein-coupled receptor for parathyroid hormone. Receptor phosphorylation is not required for agonist-induced internalisation. Mol Endocrinol 12 (1998) 1846-1856
17. Massfelder T., Stewart A.F., Endlich K., Soifer N., Judes C., and Helwig J.J. Parathyroid hormone-related protein detection and interaction with NO and cyclic AMP in the renovascular system. Kidney Int 50 (1996) 1591-1603
18. Mok L.L., Ajiwe E., Martin T.J., Thompson J.C., and Cooper C.W. Parathyroid hormone-related protein relaxes rat gastric smooth muscle and shows cross-desensitization with parathyroid hormone. J Bone Miner Res 4 (1989) 433-439
19. Muscari C., Bonafe F., Gamberini C., Giordano E., Tantini B., Fattori M., et al. Early preconditioning prevents the loss of endothelial nitric oxide synthase and enhances its activity in the ischemic/reperfused rat heart. Life Sci 74 (2004) 1127-1137
20. Nickols G.A., Nickols M.A., and Helwig J.J. Binding of parathyroid hormone and parathyroid hormone-related protein to vascular smooth muscle of rabbit renal microvessels. Endocrinology 126 (1990) 721-727
21. Nyby M.D., Hino T., Berger M.E., Ormsby B.L., Golub M.S., and Brickman A.S. Desensitization of vascular tissue to parathyroid hormone and parathyroid hormone-related protein. Endocrinology 136 (1995) 2497-2504
22. Okano K., Wu S., Huang X., Pirola C.J., Juppner H., Abou-Samra A.B., et al. Parathyroid hormone (PTH)/PTH-related protein (PTHrP) receptor and its messenger ribonucleic acid in rat aortic vascular smooth muscle cells and UMR osteoblast-like cells: cell-specific regulation by angiotensin-II and PTHrP. Endocrinology 135 (1997) 1093-1099
23. Parratt J.R., Vegh A., and Papp J.G. Bradykinin as an endogenous myocardial protective substance with particular reference to ischemic preconditioning-a brief review of the evidence. Can J Physiol Pharmacol 73 (1995) 837-842
24. Parratt J.R., Vegh A., Zeitlin I.J., Ahmad M., Oldroyd K., Kazala K., et al. Bradykinin and endothelial-cardiac myocyte interactions in ischemic preconditioning. Am J Cardiol 80 (1997) 124A-131A
25. Piserchio A., Usdin T.B., and Mierke D.F. Structure of tuberoinfundibular peptide of 39 residues. J Biol Chem 275 (2000) 27284-27290
26. Ross G., Engel P., Abdallah Y., Kummer W., and Schlüter K.-D. Tuberoinfundibular peptide of 39 residues: a new mediator of cardiac function via nitric oxide production in the rat heart. Endocrinology 146 (2005) 2221-2228
27. Schlüter K.-D., Katzer C., Frischkopf K., Wenzel S., Taimor G., and Piper H.M. Expression, release, and biological activity of parathyroid hormone-related peptide from coronary endothelial cells. Circ Res 86 (2000) 946-951
28. Schlüter K.D., and Piper H.M. Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res 37 (1998) 34-41
29. Sneddon W.B., Magyar C.E., Willick G.E., Syme C.A., Galbiati F., Bisello A., et al. Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: conditional efficacy of PTH peptide fragments. Endocrinology 145 (2004) 2815-2823
30. Suva L.J., Winslow G.A., Wettenhall R.E., Hammonds R.G., Moseley J.M., Diefenbach-Jagger H., et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237 (1987) 893-896
31. Urena P., Kong X.F., Abou-Samra A.B., Juppner H., Kronenberg H.M., Potts Jr. J.T., et al. Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology 133 (1993) 617-623
32. Usdin T.B., Bonner T.I., Harta G., and Mezey E. Distribution of parathyroid hormone-2 receptor messenger ribonucleic acid in rat. Endocrinology 137 (1996) 4285-4297
33. Usdin T.B., Dobolyi A., Ueda H., and Palkovits M. Emerging functions for tuberoinfundibular peptide of 39 residues. Trends Endocrinol Metab 14 (2003) 14-19
34. Usidin T.B., Gruber C., and Bonner T.I. Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem 270 (1995) 15455-15458
35. Usdin T.B., Hoare S.R., Wang T., Mezey E., and Palkovits M. TIP39: a new neuropeptide and PTH2-receptor agonist from hypothalamus. Nat Neurosci 2 (1999) 941-943
36. Usdin T.B., Wang T., Hoare S.R., Mezey E., and Palkovits M. New members of the parathyroid hormone/parathyroid hormone receptor family: the parathyroid hormone 2 receptor and tuberoinfundibular peptide of 39 residues. Front Neuroendocrinol 4 (2000) 349-383
37. Ward H.L., Small C.J., Murphy K.G., Kennedy A.R., Ghatei M.A., and Bloom S.R. The actions of tuberoinfundibular peptide on the hypothalamo-pituitary axes. Endocrinology 142 (2001) 3451-3456
38. Wenzel S., Schorr K., Degenhardt H., Frischkopf K., Kodja G., Wiesner R.J., et al. TGF-beta(1) downregulates PTHrP in coronary endothelial cells. J Mol Cell Cardiol 33 (2001) 1181-1190